CANAKINUMAB IN THE TREATMENT OF RHEUMATIC DISEASES IN CHILDREN
The article describes international multicenter controlled studies of efficacy and safety of monoclonal antibodies towards interleukin 1β — kanakinumab — when treating cryopyrin-associated periodic syndrome and systemic juvenile idiopathic arthritis in children. The results of the studies show that...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2014-12-01
|
Series: | Вопросы современной педиатрии |
Subjects: | |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/95 |
_version_ | 1797700425819881472 |
---|---|
author | Ye. I. Alekseeva R. V. Denisova |
author_facet | Ye. I. Alekseeva R. V. Denisova |
author_sort | Ye. I. Alekseeva |
collection | DOAJ |
description | The article describes international multicenter controlled studies of efficacy and safety of monoclonal antibodies towards interleukin 1β — kanakinumab — when treating cryopyrin-associated periodic syndrome and systemic juvenile idiopathic arthritis in children. The results of the studies show that the remission of the disease occurred in 90% of patients with cryopyrin-associated periodic syndrome and in 40% of patients with systemic juvenile idiopathic arthritis. The safety profile was comparable to that of other biological agents. |
first_indexed | 2024-03-12T04:21:44Z |
format | Article |
id | doaj.art-21ffc31d284c4ee4a672ad52e3c154b4 |
institution | Directory Open Access Journal |
issn | 1682-5527 1682-5535 |
language | English |
last_indexed | 2024-03-12T04:21:44Z |
publishDate | 2014-12-01 |
publisher | "Paediatrician" Publishers LLC |
record_format | Article |
series | Вопросы современной педиатрии |
spelling | doaj.art-21ffc31d284c4ee4a672ad52e3c154b42023-09-03T10:32:54Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352014-12-0113691410.15690/vsp.v13i6.119595CANAKINUMAB IN THE TREATMENT OF RHEUMATIC DISEASES IN CHILDRENYe. I. Alekseeva0R. V. Denisova1Научный центр здоровья детей, Москва;, Первый Московский государственный медицинский университет им. И.М. СеченоваНаучный центр здоровья детей, МоскваThe article describes international multicenter controlled studies of efficacy and safety of monoclonal antibodies towards interleukin 1β — kanakinumab — when treating cryopyrin-associated periodic syndrome and systemic juvenile idiopathic arthritis in children. The results of the studies show that the remission of the disease occurred in 90% of patients with cryopyrin-associated periodic syndrome and in 40% of patients with systemic juvenile idiopathic arthritis. The safety profile was comparable to that of other biological agents.https://vsp.spr-journal.ru/jour/article/view/95детиканакинумабсистемный ювенильный идиопатический артриткриопиринассоциированные периодические синдромы |
spellingShingle | Ye. I. Alekseeva R. V. Denisova CANAKINUMAB IN THE TREATMENT OF RHEUMATIC DISEASES IN CHILDREN Вопросы современной педиатрии дети канакинумаб системный ювенильный идиопатический артрит криопиринассоциированные периодические синдромы |
title | CANAKINUMAB IN THE TREATMENT OF RHEUMATIC DISEASES IN CHILDREN |
title_full | CANAKINUMAB IN THE TREATMENT OF RHEUMATIC DISEASES IN CHILDREN |
title_fullStr | CANAKINUMAB IN THE TREATMENT OF RHEUMATIC DISEASES IN CHILDREN |
title_full_unstemmed | CANAKINUMAB IN THE TREATMENT OF RHEUMATIC DISEASES IN CHILDREN |
title_short | CANAKINUMAB IN THE TREATMENT OF RHEUMATIC DISEASES IN CHILDREN |
title_sort | canakinumab in the treatment of rheumatic diseases in children |
topic | дети канакинумаб системный ювенильный идиопатический артрит криопиринассоциированные периодические синдромы |
url | https://vsp.spr-journal.ru/jour/article/view/95 |
work_keys_str_mv | AT yeialekseeva canakinumabinthetreatmentofrheumaticdiseasesinchildren AT rvdenisova canakinumabinthetreatmentofrheumaticdiseasesinchildren |